These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25505143)

  • 41. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
    Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
    RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A CRISPR-associated factor Csa3a regulates DNA damage repair in Crenarchaeon Sulfolobus islandicus.
    Liu Z; Sun M; Liu J; Liu T; Ye Q; Li Y; Peng N
    Nucleic Acids Res; 2020 Sep; 48(17):9681-9693. PubMed ID: 32833023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerance of Sulfolobus SMV1 virus to the immunity of I-A and III-B CRISPR-Cas systems in Sulfolobus islandicus.
    Guo T; Han W; She Q
    RNA Biol; 2019 Apr; 16(4):549-556. PubMed ID: 29629622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity.
    Zhang J; Rouillon C; Kerou M; Reeks J; Brugger K; Graham S; Reimann J; Cannone G; Liu H; Albers SV; Naismith JH; Spagnolo L; White MF
    Mol Cell; 2012 Feb; 45(3):303-13. PubMed ID: 22227115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus.
    Zebec Z; Manica A; Zhang J; White MF; Schleper C
    Nucleic Acids Res; 2014 Apr; 42(8):5280-8. PubMed ID: 24603867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of Cas8 in type I CRISPR interference.
    Cass SD; Haas KA; Stoll B; Alkhnbashi OS; Sharma K; Urlaub H; Backofen R; Marchfelder A; Bolt EL
    Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hot and crispy: CRISPR-Cas systems in the hyperthermophile Sulfolobus solfataricus.
    Zhang J; White MF
    Biochem Soc Trans; 2013 Dec; 41(6):1422-6. PubMed ID: 24256231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex.
    Zhu X; Ye K
    Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorescence-based methods for measuring target interference by CRISPR-Cas systems.
    Phan PT; Schelling M; Xue C; Sashital DG
    Methods Enzymol; 2019; 616():61-85. PubMed ID: 30691655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas.
    Sofos N; Feng M; Stella S; Pape T; Fuglsang A; Lin J; Huang Q; Li Y; She Q; Montoya G
    Mol Cell; 2020 Sep; 79(5):741-757.e7. PubMed ID: 32730741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of CRISPR RNA biogenesis and Cas6 cleavage-mediated inhibition of a provirus in the haloarchaeon Haloferax mediterranei.
    Li M; Liu H; Han J; Liu J; Wang R; Zhao D; Zhou J; Xiang H
    J Bacteriol; 2013 Feb; 195(4):867-75. PubMed ID: 23243301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptome changes in STSV2-infected Sulfolobus islandicus REY15A undergoing continuous CRISPR spacer acquisition.
    León-Sobrino C; Kot WP; Garrett RA
    Mol Microbiol; 2016 Feb; 99(4):719-28. PubMed ID: 26514343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR-Cas type I-A Cascade complex couples viral infection surveillance to host transcriptional regulation in the dependence of Csa3b.
    He F; Vestergaard G; Peng W; She Q; Peng X
    Nucleic Acids Res; 2017 Feb; 45(4):1902-1913. PubMed ID: 27980065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomics and genetics of Sulfolobus islandicus LAL14/1, a model hyperthermophilic archaeon.
    Jaubert C; Danioux C; Oberto J; Cortez D; Bize A; Krupovic M; She Q; Forterre P; Prangishvili D; Sezonov G
    Open Biol; 2013 Apr; 3(4):130010. PubMed ID: 23594878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Archaeal CRISPR-based immune systems: exchangeable functional modules.
    Garrett RA; Vestergaard G; Shah SA
    Trends Microbiol; 2011 Nov; 19(11):549-56. PubMed ID: 21945420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity.
    Samai P; Pyenson N; Jiang W; Goldberg GW; Hatoum-Aslan A; Marraffini LA
    Cell; 2015 May; 161(5):1164-1174. PubMed ID: 25959775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of the CRISPR interference complex CSM reveals key similarities with cascade.
    Rouillon C; Zhou M; Zhang J; Politis A; Beilsten-Edmands V; Cannone G; Graham S; Robinson CV; Spagnolo L; White MF
    Mol Cell; 2013 Oct; 52(1):124-34. PubMed ID: 24119402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo activity of CRISPR-mediated virus defence in a hyperthermophilic archaeon.
    Manica A; Zebec Z; Teichmann D; Schleper C
    Mol Microbiol; 2011 Apr; 80(2):481-91. PubMed ID: 21385233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Substrate generation for endonucleases of CRISPR/cas systems.
    Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
    J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.